Development of Novel Combination Inhalation Agents for Prevention and Treatment of COPD

• 作 者: ZhongxiZhao;YanLiu;YinWang;XiaoyanJiang;XiaosongZhu;
• 机 构: School of Pharmaceutical Sciences and Center for Pharmaceutical Research & DDS, Shandong University,
• 出 处: 2015年中国药物制剂大会、中国药学会药剂专业委员会2015年学术年会暨国际控释协会中国分会2015年学术年会
• 发表日期: 2015年期

　　Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide and particularly in developing countries such as China.COPD currently ranks as the fifth most common cause of death worldwide.The World Health Organization (WHO) has estimated that by 2020 it will have increased to being the third, making this a global epidemic.